Netscientific PLC
LSE:NSCI
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
51
76.5
|
Price Target |
|
We'll email you a reminder when the closing price reaches GBX.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one NSCI stock under the Base Case scenario is 58.14 GBX. Compared to the current market price of 51 GBX, Netscientific PLC is Undervalued by 12%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Netscientific PLC
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for NSCI cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Netscientific PLC
Balance Sheet Decomposition
Netscientific PLC
Current Assets | 1.4m |
Cash & Short-Term Investments | 365k |
Receivables | 830k |
Other Current Assets | 156k |
Non-Current Assets | 21.1m |
Long-Term Investments | 18m |
PP&E | 394k |
Intangibles | 2.8m |
Current Liabilities | 3.6m |
Accounts Payable | 840k |
Accrued Liabilities | 1.3m |
Short-Term Debt | 165k |
Other Current Liabilities | 1.3m |
Non-Current Liabilities | 1m |
Long-Term Debt | 1.8m |
Other Non-Current Liabilities | -720k |
Earnings Waterfall
Netscientific PLC
Revenue
|
1.4m
GBP
|
Cost of Revenue
|
-219k
GBP
|
Gross Profit
|
1.2m
GBP
|
Operating Expenses
|
-5.1m
GBP
|
Operating Income
|
-3.9m
GBP
|
Other Expenses
|
1.2m
GBP
|
Net Income
|
-2.6m
GBP
|
Free Cash Flow Analysis
Netscientific PLC
GBP | |
Free Cash Flow | GBP |
NSCI Profitability Score
Profitability Due Diligence
Netscientific PLC's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
Score
Netscientific PLC's profitability score is 35/100. The higher the profitability score, the more profitable the company is.
NSCI Solvency Score
Solvency Due Diligence
Netscientific PLC's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Score
Netscientific PLC's solvency score is 44/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NSCI Price Targets Summary
Netscientific PLC
According to Wall Street analysts, the average 1-year price target for NSCI is 139.74 GBX with a low forecast of 138.37 GBX and a high forecast of 143.85 GBX.
Dividends
Current shareholder yield for NSCI is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
NetScientific Plc is a healthcare medical technology company, which engages in sourcing, funding, and commercializing technologies that improve the health and well-being of people with chronic diseases. Its portfolio consists of a combination of direct investments and capital under advisory. The company has developed a customized investment and realization strategy for its portfolio companies through management, incubation, advisory services and fund-raising support. The company facilitates the companies it works with, to access the type of funding, management support and resources specific to their sector, stage of development and available opportunities. The firm's subsidiaries include EMV Capital Limited, Glycotest, Inc. and ProAxsis Limited, among others.
Officers
The intrinsic value of one NSCI stock under the Base Case scenario is 58.14 GBX.
Compared to the current market price of 51 GBX, Netscientific PLC is Undervalued by 12%.